Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung Cancer
Yan Xing(Shanghai First People's Hospital), Jinhua Zhao(Shanghai First People's Hospital)
Cited by 162
Related Papers
Anti-metastatic effect of 131I-labeled Buthus�martensii Karsch chlorotoxin in gliomas
|International Journal of Molecular Medicine|2018|12